Pharma Has Kept M&A Spending Small This Year, With Just One Deal Topping $5B
Pharma had an appetite for M&A this year as expected but it seems the industry was more interested in snacking than buying a whole turkey. The largest deal announced by far was Novo Holdings’ proposed $16.5 billion buyout of contract development and …